山东威高集团医用高分子制品股份有限公司（01066）于2026年2月9日回购14万股H股股份。该次回购每股价格介乎5.25港元至5.29港元，总金额约73.86万港元。
回购前，公司已发行股份为4,481,523,924股，库藏股为40,808,400股。是次交易后，公司已发行股份减少至4,481,383,924股，库藏股增至40,948,400股。此次回购股份占回购前已发行股本约0.0031%。公司于2025年5月27日获股东大会通过回购授权，授权可回购股份总数为451,560,392股，目前已回购合计34,300,000股。
公司同时确认已遵循所有相关上市规则及法律规定，并获得董事会授权。公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.